Philips is a health technology company focused on professional medical equipment and consumer health products. The company's Health Systems business (~79% of revenue) spans diagnostic imaging (MRI, CT, ultrasound, X-ray), image-guided therapy systems used in catheterization labs and interventional radiology, patient monitoring equipment, healthcare informatics software, and sleep and respiratory care devices. Philips sells primarily through a direct sales force in larger markets and distributors in smaller ones. The remaining ~21% of revenue comes from Personal Health, which sells grooming devices, electric toothbrushes, and mother and child care products through major retailers and direct-to-consumer channels. Philips' business model combines one-time capital equipment sales to hospitals with a growing base of recurring revenue from multi-year service contracts, software subscriptions, and consumables. The company has been expanding "Enterprise Monitoring as-a-Service" models, where health systems pay recurring fees rather than upfront capital. Philips also earns royalty income from licensing its large IP portfolio. A key overhang is the 2021 Respironics recall, which has resulted in several billion euros in cumulative charges and a consent decree with the FDA that prevents Respironics from selling new CPAP and BiPAP devices in the US. An ongoing DOJ investigation adds further uncertainty. North America is Philips' largest geography at roughly 42% of revenue and its primary growth driver, with strong hospital demand for imaging and monitoring equipment.